Ganeden continues Canadian expansion with new Health Canada approvals
As a result of recent regulatory work, Ganeden has made advancements for the usage of its patented and shelf-stable probiotic strain, GanedenBC30 (Bacillus coagulans GBI-30 6086), in Canada. The international leader in probiotic ingredients received a no objection letter from Health Canada, which provides further support for approved probiotic wording and allows Canadian companies fortifying with GanedenBC30 to make additional health claims.
The no objection letter from Health Canada confirms that products fortified with GanedenBC30 can make any of the general health claims that are allowed in the country’s probiotic monograph, and also provides opportunities for new gut flora language on packaging. This new approval makes it easier for companies to educate consumers on the benefits of GanedenBC30 on their food and beverage product packaging.
“Canada has become a strong market for probiotic fortification in foods and beverages, and we are dedicated to advancing regulatory approvals and probiotic language both there and internationally,” said Dr. David Keller, vice president of scientific operations for Ganeden. “Our goal as a leader in the space is to make it as easy as possible for food and beverage manufacturers to fortify with a high-quality probiotic ingredient, and to also provide direction on probiotic-related health claims and educational content.”
Probiotics are in high demand worldwide, and Canada is no exception. Ganeden is already a well-known name in the Canadian probiotic industry, partnering with many food and beverage manufacturers to fortify GanedenBC30 into a variety of everyday products. The science-backed probiotic strain is best known for its efficacy and stability, which allows it to survive most manufacturing processes, shelf life and gastric transit—opening up endless opportunities for fortification in foods and beverages where other probiotic strains are often unable to survive.
Ganeden plans to continue its expansion and partnerships in the Canadian market, with multiple new probiotic products currently in development—many of which are expected to launch this year. Experts from the team will be exhibiting at Canadian Health Food Association (CHFA) East in Toronto (booth #2307), and will be available to discuss details. For more information on Ganeden, including its ingredient portfolio, research and international presence, visit GandedenProbiotics.com.